🇺🇸 FDA
Patent

US 6136787

Interleukin 1.beta. protease and interleukin 1.beta. protease inhibitors

expired A61KA61K38/00A61P

Quick answer

US patent 6136787 (Interleukin 1.beta. protease and interleukin 1.beta. protease inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Oct 24 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K38/00, A61P, A61P17/00, A61P17/02